In the News

• Liquid Biopsies May Drive Earlier Detection, Treatments (Oncology Times; Oct 20, 2021)
• Fellows in the News (Paul & Daisy Soros Fellowship; Oct 16, 2021)
• Cancers And Sepsis Being Targeted By cfDNA Liquid Biopsies (Diagnostics World; Oct 13, 2021)
• Blood-Based Biopsy for Cancer-Predisposed Patients (the Pathologist; Oct 9, 2021)
• Novel Test Distinguishes Benign from Malignant Lesions in NF1 (Medscape; Sep 6, 2021)
• Blood, urine biopsies could pave way for more personalized cancer therapy (ScienceDaily; Sep 1, 2021)
• PLOS Medicine Author Interview: Aadel Chaudhuri, MD, PhD (PLOS Medicine; Aug 31, 2021)
• Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (WashU News, Aug 31, 2021)
• In common genetic disorder, blood test reveals when benign tumors turn cancerous (NIH News, Aug 31, 2021)
• Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease (GenomeWeb; Aug 31, 2021)
• Blood Testing Distinguishes Benign Tumors From Precancerous Condition (GenomeWeb; Aug 31, 2021)
• Liquid Biopsies May Aid Diagnosis, Treatment Of Bladder, Nerve Tumors – Washington University School Of Medicine In St. Louis (Pediatric Daily News; Aug 31, 2021)
• Liquid biopsy may help diagnose and treat bladder, neuroma (Florida News Times; Aug 31, 2021)
• Editor’s Choice: PLOS Medicine Special Issue: Early Detection and Minimal Residual Disease (PLOS Medicine; Aug 31, 2021)
• Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (Siteman News, Aug 31, 2021
• Chaudhuri Lab awarded MIRA R35 ESI award (R01-equivalent of $1.97 million over 5 years to fund their liquid biopsy research (Aug 23, 2021)
• Currently Relegated for Use in Clinical Trials, MRD Is Poised to Expand Further (Targeted Oncology; Aug 16, 2021)
• Dr. Chaudhuri and Dr. Chen speak about their liquid biopsy ventures at the ICTS Precision Medicine Venture Cafe (ICTS; May 20, 2021)
• Collaborative work on liquid biopsy MPNST sarcoma detection vs. its benign precursor published on medRxiv (medRxiv; April 25, 2021)
• Dr. Chaudhuri has been chosen to lead the ctDNA working group within the Solid Tumor Therapeutics Program (STTP) at Siteman Cancer Center (STTP; April 2021)
• Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients (genomeweb; March 28, 2021)
• ctDNA MRD detection and personalized oncogenomic analysis in colorectal cancer (genomeweb Webinar; March 23, 2021)
• Liquid biopsy for colorectal cancer could guide therapy for tumors (EurekAlert; Feb 12, 2021)
• Liquid biopsy for colorectal cancer could guide treatment (Siteman News; Feb 2021)
• Liquid biopsy for colorectal cancer: Blood and urine samples identify disease that lingers after initial therapy (WashU News; Feb 12, 2021)
• Liquid biopsy for colorectal cancer could guide treatment (NewsWise; Feb 12, 2021)
• Dr. Chaudhuri leads team selected to win Wash U Leadership & Entrepreneurship Acceleration Program (Skandalaris Ctr News; Dec 14, 2020)
• Dr. Chaudhuri is a recipient of the V Foundation V Scholar Award (Siteman News; Nov 24, 2020)
• Chaudhuri receives V Scholar Award (WashU Radiation Oncology Departmental News; Nov 19, 2020)
• Dr. Aadel Chaudhuri awarded the V Scholar Award from the V Foundation (WashU News; Nov 19, 2020)
• Dr. Aadel Chaudhuri presents at the European Association for Cancer Research (EACR) Liquid Biopsy Virtual Event (EACR; Nov 19, 2020)
• Cell-Free DNA Analysis Could Aid in Detection, Optimal Management of Resistant Metastatic Prostate Cancer (OncLive News; Aug 18, 2020)
• Conversation with Aadel Chaudhuri MD PhD Part 1 | Part 2 | Part 3 (Cancer Research Foundation; July 22, 2020)
• Blood test for metastatic prostate cancer could suggest better treatment options (Siteman News; June 18, 2020)
• The Chaudhuri lab’s ctDNA analysis and enrollment protocol titled “Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors” is now on ClinicalTrials.gov under ID# NCT04354064 (ClinicalTrials.gov; April 2020)
• Aadel Chaudhuri MD PhD quoted by The Scientist regarding his perspective on conference cancellations in the wake of Coronavirus (The Scientist; March 2020)
• Aadel Chaudhuri MD PhD receives a grant from the Institute of Clinical and Translational Sciences to research urine tumor DNA in bladder cancer (Wash U Radiation Oncology News; Jan 2020)
• Alvin J. Siteman fund grants $600,000 to Aadel Chaudhuri MD PhD, Chris Maher PhD, and Russell Pachynski MD for advanced-stage prostate cancer research (Siteman News; Dec 2019)
• Nadja Pejovic, medical student in Dr. Chaudhuri’s lab, delivers an oral presentation at the Radiation Research Society meeting in the session Imaging and Circulating Biomarkers of Radiation Response (Wash U Rad Onc News; Nov 2020)
• Aadel Chaudhuri MD PhD quoted in Cancer Discovery article on the recent TRACERx papers published in Nature Medicine (Cancer Discovery; Nov 2019)
• Aadel Chaudhuri MD PhD mentioned as part of the team led by Aaron Newman PhD that developed the CIBERSORTx computational tool for high-resolution in silico tissue dissection (Stanford Medicine News; May 2019)
• Aadel Chaudhuri MD PhD awarded a NCI K08 award to study ctDNA as a liver cancer biomarker (Wash U Rad Onc News; March 2019)
• Aadel Chaudhuri MD PhD mentioned as part of the team behind urine DNA test for bladder cancer detection (Stanford Medicine News; Jan 2019)
• Aadel Chaudhuri MD PhD named a 2018 CRF Young Investigator Award winner (Cancer Research Foundation; Dec 2018)
• Aadel Chaudhuri MD PhD interviewed on using liquid biopsies to assess radiotherapy response (Imaging Technology News; Nov 2018)
• Aadel Chaudhuri MD PhD named 2018 awardee of the Pancreatic Cancer Career Enhancement Program (SPORE; July 2018)
• Aadel Chaudhuri MD PhD wins Roentgen Research Award (RSNA; July 2018)
• Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer (Cancer Discovery; Dec 2018)
• Video interview of Aadel Chaudhuri MD PhD and Maximilian Diehn MD PhD: ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy (cancerNetwork; Nov 14, 2017)
• Lung Cancer Recurrence, Predictable at Last? (Inside Science; Nov 8, 2017)
• Blood Test for Tumor Cell DNA May Help Predict Localized NSCLC (Oncology Times; Nov 2017)
• ASTRO presents award for top resident conference abstract to Aadel Chaudhuri MD PhD (HemOnc Today; Oct 15, 2017)
• ASTRO 2017: Predicting Response to Lung Cancer Treatment With Circulating Tumor DNA Analysis (JNCCN360; Oct 2, 2017)
• Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (Imaging Technology News; Sep 29, 2017)
• Predicting lung cancer recurrence by analyzing circulating tumor DNA (Scope, Stanford Medicine’s blog; Sep 28, 2017)
• Liquid Biopsy May Show Poor Prognosis in Early NSCLC (Medpage Today; Sep 27, 2017)
• Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (The ASCO Post; Sep 26, 2017)
• Biomarker blood test predicts survival following localized lung cancer treatment (Markets Insider; Sep 24, 2017)
• Biomarker blood test predicts survival following localized lung cancer treatment (ASTRO; Sep 23, 2017)
• ASTRO honors 43 researchers including Aadel Chaudhuri MD PhD who won the Clinical/Basic Science Research Award for top resident abstract at the 2017 Annual Meeting (ASTRO; Aug 30, 2017)
• Does Plasma-Based Molecular Testing Have a Role in the Routine Care of Lung Cancer? (Clinical Advances in Hematology & Oncology; Aug 2017)
• 2017 Conquer Cancer Foundation Grants and Awards Ceremony honors Aadel Chaudhuri MD PhD for winning Young Investigator Award (ASCO; June 4, 2017)
• Aadel Chaudhuri MD PhD wins RSNA Research Resident/Fellow Grant (RSNA; March 2017)